In all nine patients mononuclear cells were isolated from peripheral blood by FicollHypaque density gradient centrifugation when acute transformation was diagnosed. The median number of blast cells in the specimens studied was 57% (ranging from 31% to 92%). (10) months). Most patients were male (78%). The most frequent clinical findings of acute leukaemia at presentation were systemic symptoms (56% of cases) (table 1). All but one patient had an enlarged spleen and 78% an enlarged liver. The haematological profile pointed to a relatively normal platelet count (>100 x 109/1) in five out of the nine patients; by contrast, all cases had severe anaemia (6-8 (2) g/dl). A pronounced bone marrow infiltration was generally observed, with a median of 77% blast cells (table 1). Because of the advanced age ofthe patients, only four were treated with aggressive chemotherapy; none of them achieved complete response. The duration of the acute phase in the whole series was 16 (8) weeks, ranging from four to 28 weeks (table 1) .
The immunophenotypic distribution of the nine patients studied is shown in table 2. In one case the blast cells only expressed HLA-DR antigens, this patient being regarded as a case of undifferentiated leukaemia. Pure myeloid blast cell proliferation was identified in five patients: two of them showed a myeloblastic phenotype (CD13+/33+; CD15-; CD14-), while in the remaining three cases the blast cells displayed either granulocytic (CD 15 + ) two cases, or monocytic (CD14+) one case, antigenic differentiation. The coexistence of two or three myeloid cell components was detected in two patients. Finally, one case had a hybrid leukaemia in which monoblasts and megakaryoblasts coexisted together with lymphoblasts (TdT+, CD19+, CD10+) (table  2) .
Because the FAB criteria cannot be applied to secondary acute leukaemias,25 a descriptive morphological classification was used. The blast cells were assigned to one of the following possible cell lineages: myeloblastic; monocytic; erythroid; megakaryocytic; and lymphoid (table 2) . Concordant findings with the immunophenotype of blast cells were achieved in five out of the nine cases. The discrepancies involved: (a) the patient with an undifferentiated phenotype showing Auer rods, who was therefore classified morphologically as a myeloblastic leukaemia; (b) the two patients with a myeloblastic phenotype that were considered on morphological and cytochemical grounds to have monocytic differentiation; and (c) the case of hybrid transformation in which the morphology identified neither the lymphoid nor the megakaryocytic component. It should be noted that the two cases of mixed myeloid leukaemias in which megakaryoblasts were detected (CD61 +, CD41 +) were recognised morphologically. The clinical features of our patients are consistent with those of the single series of acute leukaemia following idiopathic myelofibrosis,6 and most of the individual case reports.57151629 As in our study, only half the patients had received previous treatment with alkylating agents or radiotherapy,3 6 16 suggesting that the evolution into acute leukaemia might be part of the natural history of idiopathic myelofibrosis. Survival in these blast transformations is short56 16; this is probably due to both the age of the patients and to the actual nature of these leukaemias.
To the best of our knowledge, this is the first series that includes an immunophenotypic analysis of proliferating blast cells in acute leukaemias following idiopathic myelofibrosis, together with their morphological characterisation. Some previous studies, using a morphological and cytochemical approach, have shown that these leukaemias are generally myeloblastic or myelomonocytic,6 but in some case reports the existence of megakaryocytic, 13-15 erythroid,16 or lymphoid"7 transformations has been suspected on morphological grounds, as was the case in our study. Our immunological data confirm that although a typical myeloid phenotype-granulocytic or monocytic-is the one most commonly detected, other cell lineages, such as megakaryocytic, erythroid, and even lymphoid, may also be involved in these leukaemias, leading to the existence of both mixed myeloid and hybrid transformations. Despite the relatively good correlation between the morphological and immunological studies ofblast cells, our data suggest that the diagnosis and classification of blast cells in acute leukaemia following idiopathic myelofibrosis is better achieved by a combined morphological, cytochemical, and immunological approach.
Several studies have suggested that the megakaryocyte cell lineage may have an important role in the pathogenesis of idiopathic myelofibrosis. ' 32 The fact that acute myelofibrosis has been considered synonymous with acute megakaryoblastic leukaemia'01' could also suggest a preferential role for megakaryocytic cell lineages in acute leukaemias following previous idiopathic myelofibrosis. Interestingly, megakaryoblastic proliferation was detected in three of our nine cases (33%), this incidence being clearly higher than that found in the de novo acute myeloid leukaemias (11%).19 However, it should be noted that the prevalence of megakaryoblastic transformation in other myeloproliferative disorders, such as chronic myeloid leukaemia is also high-23% to 51 %. 2227 These data would therefore not confirm that there is a special association between idiopathic myelofibrosis in blastic transformation and the megakaryocytic cell lineage. Moreover, the coexistence of several cell lineages, including the lymphoid, would additionally indicate a clonal pluripotent stem cell origin for this disorder.
